At OHSU Casey Eye Institute, we are honored to work every day with ophthalmologists throughout the Pacific Northwest to help patients with eye conditions. And, in collaboration with you, we can provide the best possible eye care for your patients.

We are a world leader in eye research, including clinical trials for pioneering treatments such as  gene therapy for inherited eye conditions.

We also embrace a core part of our mission: to provide the vital education that propels ophthalmology forward. Not only do we help train the next generation of ophthalmologists, we provide regular continuing education opportunities and conferences for our ophthalmology colleagues throughout Oregon, the region and the world.

Here are details on how we can partner with you to provide the highest quality care for patients -- and how together we can reach the goal of ending preventable blindness.

Refer a patient

Learn more about referring a patient to OHSU Casey Eye Institute:

• Call 503-494-3000, or call the OHSU Physician Consult and Referral Line at 800-245-6478.
• View our Casey Referral Guide
• Complete a Casey Eye Institute Patient Referral Form if you're interested in referring a patient to us. This information will help us coordinate the best possible care with the appropriate clinic.

Continuing Medical Education

Casey is a national leader in providing continuing medical education for ophthalmologists.

Our CME program includes lectures, conferences and grand rounds courses that we conduct throughout the year. Participating physicians learn about the latest advances in eye disease and treatments from regional and national experts, including Casey faculty. Many parts of our CME program are live-streamed via the Internet, which allows physicians to participate remotely.

We also host national and international conferences that feature some of the world's leading authorities in the research and treatment of a wide range of eye disease.

The Oregon Ophthalmological Alumni Association

Members of the Oregon Ophthalmological Alumni Association are graduates of the Casey Eye Institute's residency and fellowship programs. The association holds a full-day continuing medical education meeting each year in May that coincides with the completion of the training program for Casey residents. At that meeting, the Edward N. McLean Community Service Award is given to a Casey resident judged to have made particular contributions in community service during the course of his or her residency training.

The association also holds a reception in conjunction with the annual meeting of the American Academy of Ophthalmology.

Kenneth C. Swan Library

Kenneth Swan, M.D., founded the Department of Ophthalmology at the University of Oregon Medical School (now OHSU) in 1945. Considered the "Father of Oregon Ophthalmology," Swan was the school's first full-time instructor and chair and created the first three-year ophthalmology residency program in the Pacific Northwest.

The Oregon Ophthalmological Alumni Association provides financial support to the Swan Library, whose mission is to make contemporary educational materials accessible to Casey Eye Institute residents and staff and practicing physicians in the community. Its collection includes current as well as classic literature in ophthalmology and the visual sciences. Literature search and copy services are provided in cooperation with OHSU's Biomedical Information Communication Center. For further information, you can reach the library's support staff at 503-494-3380 or by e-mail.

Diagnostic services

• The Leonard Christensen Eye Pathology Laboratory at Casey is the only full-service eye pathology laboratory in the Pacific Northwest certified through federal regulations outlined by the Clinical Laboratory Improvement Amendments of 1988. Our laboratory staff provides a range of histopathological analyses of surgical and experimental eye tissues.
• The Ocular Immunology Laboratory at Casey offers several anti-retinal autoantibody tests that can provide vital information on a range of eye conditions, including cancer-associated retinopathy (CAR), melanoma-associated retinopathy (MAR), autoimmune retinopathy and age-related macular degeneration (AMD).